$14.8 Billion is the total value of VIKING GLOBAL INVESTORS LP's 53 reported holdings in Q2 2017. The portfolio turnover from Q1 2017 to Q2 2017 was 106.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| V | Buy | VISA INC | $737,861,000 | +94.8% | 7,868,000 | +84.6% | 4.97% | +197.0% |
| WFC | New | WELLS FARGO CO NEW | $681,388,000 | – | 12,297,209 | +100.0% | 4.59% | – |
| FOXA | Buy | TWENTY FIRST CENTY FOX INCcl a | $633,414,000 | -3.6% | 22,350,523 | +10.2% | 4.27% | +47.0% |
| CRM | Buy | SALESFORCE COM INC | $409,629,000 | +91.3% | 4,730,124 | +82.2% | 2.76% | +191.6% |
| LYB | Buy | LYONDELLBASELL INDUSTRIES N | $326,701,000 | +47.4% | 3,871,318 | +59.3% | 2.20% | +124.7% |
| UHS | Buy | UNIVERSAL HLTH SVCS INCcl b | $212,687,000 | -1.1% | 1,742,195 | +0.8% | 1.43% | +50.7% |
| PH | Buy | PARKER HANNIFIN CORP | $206,515,000 | +282.7% | 1,292,171 | +283.9% | 1.39% | +484.5% |
| APC | New | ANADARKO PETE CORP | $179,772,000 | – | 3,964,984 | +100.0% | 1.21% | – |
| AFL | New | AFLAC INC | $165,754,000 | – | 2,133,804 | +100.0% | 1.12% | – |
| BABA | New | ALIBABA GROUP HLDG LTDsponsored ads | $155,119,000 | – | 1,100,913 | +100.0% | 1.04% | – |
| JAZZ | Buy | JAZZ PHARMACEUTICALS PLC | $154,396,000 | +437.8% | 992,901 | +401.9% | 1.04% | +718.9% |
| TDG | New | TRANSDIGM GROUP INC | $143,539,000 | – | 533,860 | +100.0% | 0.97% | – |
| NUVA | Buy | NUVASIVE INC | $138,492,000 | +50.5% | 1,800,463 | +46.1% | 0.93% | +129.2% |
| SHPG | Buy | SHIRE PLCsponsored adr | $131,729,000 | -3.8% | 797,053 | +1.4% | 0.89% | +46.6% |
| MOH | New | MOLINA HEALTHCARE INC | $102,167,000 | – | 1,476,832 | +100.0% | 0.69% | – |
| XRAY | Buy | DENTSPLY SIRONA INC | $92,745,000 | +73.8% | 1,430,369 | +67.4% | 0.62% | +164.8% |
| GWPH | Buy | GW PHARMACEUTICALS PLCads | $87,549,000 | -13.3% | 873,308 | +4.6% | 0.59% | +32.3% |
| RJF | New | RAYMOND JAMES FINANCIAL INC | $76,716,000 | – | 956,318 | +100.0% | 0.52% | – |
| AVXS | Buy | AVEXIS INC | $73,390,000 | +152.9% | 893,258 | +134.1% | 0.49% | +285.9% |
| FLT | New | FLEETCOR TECHNOLOGIES INC | $68,455,000 | – | 474,690 | +100.0% | 0.46% | – |
| NSC | New | NORFOLK SOUTHERN CORP | $57,208,000 | – | 470,075 | +100.0% | 0.38% | – |
| LOW | New | LOWES COS INC | $57,066,000 | – | 736,048 | +100.0% | 0.38% | – |
| MMC | New | MARSH & MCLENNAN COS INC | $54,427,000 | – | 698,142 | +100.0% | 0.37% | – |
| ANTM | New | ANTHEM INC | $53,933,000 | – | 286,680 | +100.0% | 0.36% | – |
| ZBH | New | ZIMMER BIOMET HLDGS INC | $51,059,000 | – | 397,654 | +100.0% | 0.34% | – |
| KITE | New | KITE PHARMA INC | $49,778,000 | – | 480,155 | +100.0% | 0.34% | – |
| EXPE | New | EXPEDIA INC DEL | $47,660,000 | – | 319,974 | +100.0% | 0.32% | – |
| HDB | Buy | HDFC BANK LTD | $39,272,000 | +19.0% | 451,554 | +2.9% | 0.26% | +80.8% |
| XOGAQ | Buy | EXTRACTION OIL AND GAS INC | $38,187,000 | -23.9% | 2,839,191 | +5.0% | 0.26% | +15.8% |
| CALA | Buy | CALITHERA BIOSCIENCES INC | $35,942,000 | +35.0% | 2,420,317 | +5.0% | 0.24% | +105.1% |
| New | NEURODERM LTD | $21,196,000 | – | 708,898 | +100.0% | 0.14% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| VISA INC | 36 | Q3 2023 | 7.0% |
| AMAZON COM INC | 34 | Q3 2023 | 10.6% |
| META PLATFORMS INC | 34 | Q3 2023 | 10.4% |
| MICROSOFT CORP | 30 | Q3 2023 | 9.1% |
| THERMO FISHER SCIENTIFIC INC | 29 | Q3 2023 | 5.4% |
| NETFLIX INC | 26 | Q2 2023 | 6.0% |
| MASTERCARD INCORPORATED | 25 | Q3 2023 | 3.9% |
| ELEVANCE HEALTH INC | 24 | Q2 2023 | 10.2% |
| ALPHABET INC | 22 | Q2 2021 | 9.3% |
| UNITEDHEALTH GROUP INC | 22 | Q3 2023 | 5.3% |
View VIKING GLOBAL INVESTORS LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Celldex Therapeutics, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| Coupa Software IncSold out | February 14, 2023 | 0 | 0.0% |
| FIGS, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| Guardant Health, Inc. | February 14, 2023 | 4,107,644 | 4.0% |
| Orion Acquisition Corp.Sold out | February 14, 2023 | 0 | 0.0% |
| PROCEPT BioRobotics CorpSold out | February 14, 2023 | 0 | 0.0% |
| Frazier Lifesciences Acquisition CorpSold out | November 25, 2022 | 0 | 0.0% |
| Cazoo Group Ltd | November 10, 2022 | 60,000,000 | 7.3% |
| AbCellera Biologics Inc.Sold out | February 14, 2022 | 0 | 0.0% |
| Athira Pharma, Inc.Sold out | February 14, 2022 | 0 | 0.0% |
View VIKING GLOBAL INVESTORS LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 3 | 2024-06-07 |
| SC 13G | 2024-06-07 |
| 4 | 2024-06-03 |
| SC 13G/A | 2024-06-03 |
| 13F-HR | 2024-05-15 |
| 3 | 2024-03-20 |
| SC 13G/A | 2024-03-20 |
| 4 | 2024-03-07 |
| 4 | 2024-03-07 |
| 4 | 2024-03-01 |
View VIKING GLOBAL INVESTORS LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.